Anavex Life Sciences Corp (AVXL): Boom. A2-73 worth 10 Billion.imo. In N...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	18
Posts	1457
Boards Moderated	0
Alias Born	11/01/2018

bb8675309

Re: None

Monday, 12/28/2020 11:02:08 AM

Monday, December 28, 2020 11:02:08 AM

Boom. A2-73 worth 10 Billion.imo.
In November 2020, Anavex presented data at the 13th Clinical Trials on Alzheimer’s Disease (CTAD) 2020 Conference, reporting top-line results from the proof-of-concept Phase 2 placebo-controlled trial with primary objectives of safety, tolerability, and efficacy in cognition of ANAVEX®2-73 in patients in Parkinson’s disease dementia (PDD) compared to placebo. Both primary objectives of the study were met. The results show clinically meaningful, dose-dependent, and statistically significant improvements in the Cognitive Drug Research (CDR) computerized assessment system analysis. The study confirmed the precision medicine approach of targeting SIGMAR1 as a genetic biomarker in response to ANAVEX®2-73 supporting progression to further development in upcoming Phase 2/3 studies

https://finance.yahoo.com/news/anavex-life-sciences-reports-fiscal-120000990.html